Início › DPOC › Texas › Dallas
Ensaios clínicos de DPOC em Dallas, TX
12 estudos para DPOC estão buscando participantes em locais em Dallas e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
RecrutandoFase 3
- Texas Health Presbyterian Hospital Dallas- Site Number : 8400032, Dallas
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Recrutando
- University of Texas Southwestern, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
RecrutandoFase 3
- IntraCare- Site Number : 8400034, Dallas
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
RecrutandoFase 2
- Research Site, Dallas
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
RecrutandoFase 3
- Research Site, Dallas
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
RecrutandoFase 2/3
- Alina Clinical Trials, LLC., Dallas
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
RecrutandoFase 3
- Research Site, Dallas
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
RecrutandoFase 3
- GC2501 Study Site 109, Dallas
STRIVE Post-Market Registry Study
RecrutandoEstudo observacional
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern, Dallas
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
RecrutandoFase 3
- GSK Investigational Site, Dallas
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
RecrutandoEstudo observacional
- Liver Center of Texas, Dallas
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
RecrutandoFase 3
- GSK Investigational Site, Dallas
Ensaios de DPOC em outras cidades
- Philadelphia, PA22 estudos
- Miami, FL18 estudos
- Birmingham, AL17 estudos
- Boston, MA17 estudos
- Orlando, FL15 estudos
- Houston, TX15 estudos
- Chicago, IL14 estudos
- Baltimore, MD13 estudos
- Pittsburgh, PA12 estudos
- New York City, NY11 estudos
- Winston-Salem, NC9 estudos
- Charlotte, NC9 estudos
Outros estudos em Dallas
- Câncer de Mama54 estudos
- Câncer de Pulmão de Não Pequenas Células52 estudos
- Insuficiência Cardíaca42 estudos
- Câncer Metastático42 estudos
- Câncer (todos os tipos)38 estudos
- Câncer de Próstata36 estudos
- Câncer Colorretal33 estudos
- Obesidade31 estudos
- Câncer de Ovário28 estudos
- Câncer de Bexiga27 estudos
- Câncer de Pulmão27 estudos
- Câncer Endometrial25 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 1 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.